Peer-reviewedCC BYBiomolecules
Psoriasis and Bullous Pemphigoid: An Updated Review of Clinical Association, Targeted Therapy Exposures and Therapeutic Implications
Related
- A metabolic perspective on eIF1A and eIF3B inhibition as a potential therapeutic strategy in psoriasis
- Editorial: E3 ubiquitin ligases: critical roles in cancer progression and therapeutic implications
- Navigating the Biomolecular Corona: Biological Interactions and Therapeutic Implications of RNA–Lipid Nanoparticles
- Cancer-associated fibroblasts in head and neck tumours: signalling networks and therapeutic implications with insights from vestibular schwannoma
- Spatial multi-omics uncovers an invasive-desmoplastic cellular community with prognostic and therapeutic implications in pancreatic ductal adenocarcinoma
BibTeX
@article{anon2026psoriasis,
title = {{Psoriasis and Bullous Pemphigoid: An Updated Review of Clinical Association, Targeted Therapy Exposures and Therapeutic Implications}},
journal = {Biomolecules},
year = {2026},
month = sep,
url = {https://europepmc.org/article/PMC/PMC13702189},
note = {CC BY},
}
RIS
TY - JOUR
TI - Psoriasis and Bullous Pemphigoid: An Updated Review of Clinical Association, Targeted Therapy Exposures and Therapeutic Implications
PY - 2026
DA - 2026/09/24
JO - Biomolecules
UR - https://europepmc.org/article/PMC/PMC13702189
SN - 2218-273X
ER -